Guaifenesin Extended Release 1200 Mg Tablet
Product Images NDC 49483-724

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Guaifenesin Extended Release 1200 Mg (NDC 49483-724). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Time Cap Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Guaifenesin-1200mg-70ct-label (Guaifenesin 1200mg 70ct Label)

Drug Facts panel for Guaifenesin Extended Release 1200 mg tablets includes active ingredient details, purpose as an expectorant, uses, warnings, directions, other information, and inactive ingredients. The panel provides dosage instructions, safety warnings for specific groups, storage conditions, and contact number for questions or comments.*

FDA Label Image

Guaifenesin-600mg-500ct-label (Guaifenesin 600mg 500ct Label)

Label for Timely Guaifenesin Extended Release 600 mg tablets, oral expectorant. The package contains 500 extended-release tablets. The label highlights 12-hour relief, active ingredient guaifenesin USP 600 mg per tablet, and is distributed by Time-Cap Laboratories, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.